GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
34.98
+0.67 (1.95%)
Dec 3, 2024, 1:49 PM EST - Market open
GSK Revenue
GSK had revenue of 8.01B GBP in the quarter ending September 30, 2024, a decrease of -1.66%. This brings the company's revenue in the last twelve months to 31.31B, up 5.59% year-over-year. In the year 2023, GSK had annual revenue of 30.33B with 3.42% growth.
Revenue (ttm)
31.31B GBP
Revenue Growth
+5.59%
P/S Ratio
n/a
Revenue / Employee
445,949 GBP
Employees
70,212
Market Cap
69.22B USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 30.33B | 1.00B | 3.42% |
Dec 31, 2022 | 29.32B | 4.63B | 18.74% |
Dec 31, 2021 | 24.70B | 342.00M | 1.40% |
Dec 31, 2020 | 24.35B | -9.40B | -27.85% |
Dec 31, 2019 | 33.75B | 2.93B | 9.52% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CVS Health | 367.25B |
McKesson | 330.19B |
Cencora | 293.96B |
HCA Healthcare | 69.62B |
Takeda Pharmaceutical | 31.73B |
Becton, Dickinson and Company | 20.18B |
Haleon | 15.07B |
Regeneron Pharmaceuticals | 13.85B |
GSK News
- 11 days ago - GSK's RSV vaccine gets Japan approval for adults aged 50 to 59 - Reuters
- 14 days ago - GSK share price is imploding: is it safe to buy the dip? - Invezz
- 14 days ago - GSK drug meets main goal in late-stage study to treat relentless itch - Reuters
- 17 days ago - As Drug Maker Stocks Fall, Pressure Builds On PhRMA To Derail RFK, Jr. - Forbes
- 18 days ago - GSK plc (GSK) Guggenheim's Inaugural Healthcare Innovation Conference (Transcript) - Seeking Alpha
- 18 days ago - European And US Vaccine Stocks Are Under Pressure - Here's WHy - Benzinga
- 18 days ago - Pharma shares hit as Trump picks RFK Jr to lead health department - The Guardian
- 18 days ago - Vaccine maker stocks fall on reports Trump plans to tap RFK Jr. to lead HHS - CNBC